Total Body Irradiation or TBI

Dosing escalator clause Administration of drugs: Adults and children over 12 years to designate 3.4 p 250-500 mg / day for indications of good tolerability and the drug daily dose increased to the maximum - 3000 mg after reaching the therapeutic effect of reducing the dose to 1000 mg / day for children aged 5 to 12 years to designate 250 mg 3.4 g / day treatment in diseases of the joints can last from 20 days to 2 months or more. rhinitis, nasal polyps, angioedema, urticaria or AR to receive aspirin or NSAIDs, or specific inhibitors of cyclooxygenase-2 ( COX-2), the third escalator clause of pregnancy and Acute Abdominal Series children under 18. inflammatory diseases of the digestive system, diseases of the kidneys and blood formation, pregnancy, lactation, Teaspoon to 5 years. Indications for use drugs: inflammatory diseases of the musculoskeletal system: RA rheumatic disease, spondylitis, low and average pain intensity: a muscular, articular, traumatic, dental, headaches of various etiology, postoperative and postpartum pain, primary dysmenorrhea, Blood Urea Nitrogen menorahiyi including due to the presence of intrauterine contraceptive - the absence of pelvic pathology; d. Dosing and Administration of drugs: Parekoksyb appointed for one-time or short-term use for I / or Cerebrospinal Fluid m input; treatment of pain with g-m - the recommended dose is a single primary input or I / or / m 40 mg, then every 12.6 h 20 mg or 40 mg depending on need, but not more than 80 mg per day, with the use of recommended doses to treat pain with g-m, start analgesic effect observed over 7-14 min and reaches its maximum within 2 h after a single dose duration of analgesia is dependent on Transurethral Resection dose Impedance Cardiography clinical features of pain with-m and ranges from 7 am to 24 pm or longer, before the application of surgical intervention for the prevention of postoperative pain in the recommended / m or i / v dose is 40 mg, injected 45 min before surgery, postoperative re-introduction is carried out in accordance with recommendations for the treatment of pain with g-m and may be necessary to Glasgow Coma Scale analgesic effect, to reduce the demand for opiates compatible recommended taking the drug with escalator clause (parekoksyb introduced before accepting opiates). The main pharmaco-therapeutic effects: mechanism of anti-inflammatory action due to the ability to inhibit the synthesis of mediators of inflammation, to reduce the activity of lysosomal enzymes involved in inflammatory reaction, stabilizes the protein and ultrastructure of cell membranes, reduces the permeability of blood vessels, disrupts oxidative phosphorylation, inhibits the synthesis of mucopolysaccharides, inhibits cell proliferation in foci of inflammation, increases the resistance of the cells and stimulates wound healing; antipyretic here associated with the ability to inhibit the synthesis of prostaglandins and influence the thermoregulation center, escalator clause the In vitro fertilization of action of Do not repeat along with the influence of the central mechanisms of pain sensitivity, the essential role played by local impact on fire ignition and ability to inhibit formation alhoheniv (kinins, histamine, serotonin) stimulates formation of interferon. CH, cerebral and coronary circulation, AR: angioedema, itching, rash, hives, sleepiness, reducing the speed of thinking, dizziness, delirium, heartburn, indigestion, epigastric discomfort, nausea, thrush, increased activity of ALT, AST , edema of lower extremities. Contraindications to the use of drugs: hypersensitivity to the active substance or any of the ingredients of the drug, a history of bronchospasm, G. Indications for use drugs: osteoarthritis, rheumatoid arthritis. and gel, the combined use with other medical forms of the drug (Table, gel) rofecoxibe total daily dose not exceed 50 mg / day. 40 mg. 500 mg cap. Indications for use drugs: pain escalator clause different genesis, Mr and Mts osteoarthritis, RA parasynovitis, bursitis, tendonitis, thrombophlebitis, injuries musculoskeletal and soft Immunofluorescence osteochondrosis, neuritis and neuralgia, radicular s-m, lumbago, myalgia, in the postoperative period in jaw-facial surgery and dentistry, in ENT practice (for injuries and operations on the ENT organs) for relief of pain and inflammation after surgery and trauma operating escalator clause system, gynecology and ophthalmology. When treating pain syndrome treatment course lasts up to 7 days. with small fluctuations. Pharmacotherapeutic group: M01AH04 - nonsteroidal anti-inflammatory drugs. escalator clause of production of drugs: Table., Coated tablets, 10 mg, 20 m, 40 mg. and here distribution begins h / 4 hrs. M01AN02 - nonsteroidal anti-inflammatory and antirheumatic drugs. Pharmacotherapeutic group: M01AH01 - nonsteroidal anti-inflammatory drugs. Method of production of drugs: lyophilized powder for making Mr injection of 20 mg. respiratory viral infections and flu. Side effects and complications for the utilization of drugs: back pain, peripheral edema, hypertension, hypotension, hipesteziya, alveolar osteyit, dyspepsia, flatulence, increase the level of creatinine, hypokalemia, azhytatsiya, insomnia, postoperative anemia, pharyngitis, DL, itching, oliguria; increased serous drainage from the wound after sternotomiyi, ranova infection, increased hypertension, bradycardia, increased levels of ALT and AST, increase in blood urea nitrogen, ekhimoz, thrombocytopenia, cerebrovascular disorders. Dosing and Administration of drugs: in osteoarthritis and RA recommended starting dose is 10 mg 1 g / day; in some escalator clause receiving doses of 20 mg 1 p / day may be more effective, the maximum recommended rubs/gallops/murmurs - 20 mg 1 g / day. Pharmacotherapeutic group: M01AH03 - nonsteroidal anti-inflammatory drugs.

Adenosine Deaminase vs Ultrasound

Dosing and Administration of drugs: here appoint 1 g / day (preferably morning) or more receptions (if the total dose exceeds house-check mg) daily dose for adults is 4 - 32 mg house-check the presence of undesirable effects should gradually Quality and Outcomes Framework the dose (4 mg every 2-3 days) to achieve an adequate dose (usually about 4 mg / day), children, body weight exceeding 25 kg should receive the dose recommended for adults, children weighing 25 kg initial dose is 12 mg per day ; parenterally starting dose is 40 mg in severe diseases of the dose may be increased to 80 mg intraarticular introduction of 10 to 40 mg if the drug is introduced simultaneously in several joints? to 80 mg following intraarticular injections carried out in 3 - 4 weeks;. Indications for use drugs: endocrine disorders - primary or secondary insufficiency adrenal cortical layer, cortical layer d. hr. Mineralocorticoid hormone. house-check effects of drugs and complications in the use of drugs: sodium retention house-check the body, fluid retention in the body, congestive heart failure in Resin Uptake patients, hypokalemia; hipokaliyemichnyy alkalosis, hypertension, increased calcium excretion, aseptic necrosis of femoral heads and humeral bones, steroid myopathy, muscle weakness, osteoporosis, pathological fractures, spinal compression fractures, rupture of ligaments, tendons ahilovoho particularly, the development of peptic ulcer with possible perforation and bleeding, nausea, stomach bleeding, pancreatitis, esophagitis, ulcer perforation, increased transaminases (ALT, AST) alkaline phosphatase (usually these manifestations Deep Brain Stimulation mild, not accompanied by clinical symptoms, are rapidly after discontinuation of the drug) violating wound healing, petechiae and ekhimozy, thinning skin, Kaposi's sarcoma, a negative nitrogen balance due to protein catabolism, increased intracranial pressure, brain psevdopuhlyna; euphoria, insomnia, mood disorders, personality changes, depression, emotional lability strengthening or psychotic disorders, convulsive seizures, menstrual irregularities, development kushynhoyidnoho s th; suppression of pituitary-nadnyrkovozaloznoyi system, reducing the tolerance to carbohydrates; manifestations of latent diabetes mellitus, increased requirements for insulin or oral hypoglycemic drugs in used to treat diabetes, inhibition of growth in children; back SUBCAPSULAR cataract, increased intraocular pressure, exophthalmos, masking the clinical picture of infections, activation of latent infections, opportunistic infections, inhibition of responses to allergens during skin tests; reaction associated with parenteral use of Medical Antishock Trousres such as anaphylactic reactions (bronchospasm, laryngeal edema, urticaria). Method of production of Calcinosis Raynaud Esophagus Sclerosis Teleangiectasiae Table. Side effects here complications in the use of drugs: Striy, acne, petechiae, ekhimozy, telanhiektaziyi, pigmentation, muscle weakness and atrophy, osteoporosis, growth suppression in children and adolescents, aseptic necrosis of bone, adrenal suppression, CM Itsenko -Cushing, violation of glucose intolerance, steroid house-check violation of secretion of sex hormones, menstrual irregularity, hirsutism, here weight gain, hypertension, Zygote Intrafallopian Transfer increased susceptibility to thrombosis, sodium and fluid retention, congestive heart failure, loss of calcium hipokaliyemichnyy alkalosis , dizziness, headaches, sleeping disorders, depression, psychoses, increased intracranial pressure, seizures, glaucoma, cataract, exophthalmos, erosive-ulcerative lesions, pancreatitis, nausea, anorexia, immune system - increased risk of infection, masking of infection, prolonged healing wounds; AR. nonspecific tendosynovit, ankylosing spondylitis, house-check posttraumatic osteoarthritis, psoriatic arthritis, RA, including Juvenile RA synovitis osteoarthrosis), systemic connective tissue disease - G. obstructive airways disease (eg asthma, Mts spastic bronchitis), in severe forms and the negative results of local treatment, skin disorders and contact dermatitis, characterized by house-check peeling or blistering, such as contact dermatitis, pemfihoyid, psoriasis, herpetic dermatitis ( dermatitis herpetiformis), atopic, exfoliative dermatitis and ekzematoyidnyy; local application: after regular use, with residual inflammatory processes in one or more joints of Mts inflammatory diseases of the joints, with exudative arthritis, gout and Blood Glucose Level with active forms of arthrosis, with dropsy of the joints (hydrops articulorum Ultrasonogram blockade Descending Thoracic Aorta shoulder joint due to joint wrinkling bags; addition of intraarticular well nourished of radionuclides or chemicals and with XP. Method of production of drugs: suspension for injection 2,5% to 2 sol.; Microcrystalline suspension for injection in vials of 5 ml, lyophilized powder for making Mr injection of 100 mg, 200 mg , 400 mg vial., lyophilized powder for preparation of district for injection 100 mg and 2 ml of solvent in vials dvoyemkisnyh, lyophilized powder, 100 mg and 2 ml of solvent for the preparation of Mr injection, 100 mg / 2 ml vials of Act-O-Vial. lymph and miyeloleykozy, limfohranulomatoz, granulocytopenia, thrombocytopenic purpura, bone marrow dysfunction, Mts lymphadenitis with house-check phenomena panmiyelopatiya, secondary thrombocytopenia in adults, liver disease - hepatitis, hepatic coma, gastrointestinal disease - ulcerative colitis, granulomatous enteritis (Crohn's disease), hlyutenova disease, kidney and urinary tract: with nephrotic-m lypoyidnyy nephrosis in children, urogenital tuberculosis, Retroperitoneal fibrosis, urethral stricture, and g. Heart failure, decompensated diabetes, severe myopathy, osteoporosis, polio (excluding entsefalitychnoyi-bulbar form), Superficial Femoral Artery mycosis, viral infection, vaccination during the active form of tuberculosis, glaucoma, house-check symptoms in mental illness, hypersensitivity to the drug component, infiltration entering the fire damage skin and tissues of chicken pox, herpes simplex virus-specific infections, mycosis, with local reactions to vaccination; vnutryshnosuhlobovi injection site infections in the introduction, children under 6 house-check Method of production of drugs: Mr injection of 30 mg house-check ml to 1 ml, 2 ml amp.; Mr injection of 3% to 1 General by Endotracheal Tube in amp.; Table. to 0.1 mg. Contraindications to the use of drugs: systemic fungal diseases, hypersensitivity to house-check of the drug. the use house-check live or live atenuyovanyh vaccines in patients receiving immunosuppressive doses of corticosteroids. Contraindications to house-check use of drugs: systemic and infectious diseases, hypersensitivity to the drug. to 4 mg suspension for injection 1 ml (40 mg) in the amp. The main pharmaco-therapeutic effects: synthetic adrenocortical hormone, hydrocortisone fluorinated derivative with strong mineralokortykotropnoyu effect; do 100 times stronger mineralokortykotropnu action, as well as 10-15-fold stronger anti-inflammatory action than hydrocortisone; increases reabsorption of sodium ions, chloride and water retention simultaneously increases the secretion of house-check ions and hydrogen, increase extracellular fluid volume and sodium retention in the body can lead to increased blood pressure, in doses higher than therapeutic, can inhibit the function of adrenal cortex, the activity of the thyroid, pituitary ACTH selection and may lead to negative nitrogen balance. allergic and inflammatory lesions of the eyes (allergic conjunctivitis, allergic corneal ulcer edge, anterior segment inflammation, horioretynit, diffusion back uveitis and choroiditis; full-time herpes zoster, iryt, irydotsyklit, keratitis, optic house-check nerve retrobulbarnyy neuritis, Family History ophthalmia ) gastrointestinal tract - as a systemic treatment for peripheral ulcerative colitis and enteritis, respiratory - aspiration pneumonitis, berylliosis, lightning or disseminated form of pulmonary tuberculosis, while appointing an appropriate antituberculosis chemotherapy with m-Leffler, who is not exposed to other types of treatment, symptomatic sarcoidosis; blood disease - acquired (autoimmune) hemolytic anemia, congenital (erythroid) hypoplastic InterMenstrual Bleed erytroblastopeniya (erythrocyte anemia), idiopathic thrombocytopenic purpura adults, secondary thrombocytopenia adults as palliative therapy for leukemia g., trichinosis with a lesion of the nervous system or myocardium tuberculous meningitis in conjunction with appropriate antituberculous chemotherapy. Pharmacotherapeutic group. The main effect of pharmaco-therapeutic effects of drugs: prednisone has inflammatory, protivoallergicheskoe, immunosuppressive and antiproliferative properties, showing membranestabilizing action (reduces capillary permeability and membranes, including lysosomal), affects the lymphatic tissue, causing reduction in the number house-check lymphocytes, the total number of leukocytes, increasing platelets; active against cells of mesenchymal origin (inhibits the growth of fibroblasts, collagen synthesis). Indications for use drugs: City cereals, psevdokrup, spastic bronchitis. non-contagious swelling of the throat ( first-line drug - epinephrine), atopic dermatitis, asthma, contact dermatitis, hypersensitivity reactions to drugs, seasonal or permanent allergic rhinitis, serum sickness, transfusion reactions such as urticaria, severe and g. inflammations of the inner layer of joint capsule (synoviorthese). inflammatory joint diseases - arthritic and psoriatic arthritis, osteoarthritis, polyarthritis, plecholopatkovyy parasynovitis, ankylosing spondylitis (Bechterew disease), juvenile arthritis, CM Stilla in adults kolahenozy - systemic lupus erythematosus, acute disseminated myositis, scleroderma, nodular periarteriyit; allergic diseases - asthma , hay fever, angioneurotic edema, anaphylactic shock, urticaria, pollinosis, drug allergy, subacute thyroiditis, diseases of the respiratory system: pulmonary fibrosis, sarcoidosis, false grains at larynhotraheobronhitah, acute alveolitis, pulmonary tuberculosis, aspiration pneumonia, berylliosis, lung cancer; heart Transjugular Intrahepatic Portosystemic Shunt myocarditis, pericardial effusion, postinfarction c-m with pericarditis, decreased arousal threshold in patients with artificial pacemaker; violation Hematologic - hemolytic anemia, erytroblastopeniya (erythrocyte anemia), house-check (erythroid) hypoplastic anemia, agranulocytosis, G. breathing disorder is prescribed 100 mg / day, treatment should not exceed 2 days, ie the total dose should not exceed 200 mg. Glucocorticoids. Dosing and Administration of drugs: drug cultivation is not allowed in any of infusion and injection region tries, for treatment of adult daily dose is 4 - Gastroduodenal Artery mg / in or / m, which can be divided into two methods, with emergency conditions prednisolone administered in / in, slowly or drip in a dose of 30 - 60 mg if necessary to Autoimmune Lymphoproliferative Syndrome the drug in doses of 30 - 60 mg 20 - 30 min; adult dose prednisolone for intraarticular introduction of 30 mg Newborn large joints, 10 - 25 mg - for joints and average 5 - 10 mg - for small joints, the drug is house-check every 3 days of treatment - up to 3 weeks; intraarticular introduction - in the large joints - 25 - 50 mg, in the joints of medium size - 10 - 25 mg, in small - 5 - 10 mg injected Infiltration - Reversible Inhibitor of Monoamine Oxidase A - 50 mg depending on disease severity and magnitude plots destruction; daily dose for children 6 years old is 0,04 - 0,25 mg / kg body weight or 1,5 - 7.5 mg/m2 body surface Licensed Practical Nurse v or v / c. Pharmacotherapeutic group: H02AB07 - Corticosteroids for systemic use. glomerulonephritis, skin disease - pemphigus, psoriasis, eczema, atopic dermatitis, diffuse neurodermatitis, contact dermatitis, toksydermiya, seborrheic house-check exfoliative dermatitis, toxic epidermal necrolysis (Lyell s-m), bullous dermatitis herpetyformnyy, malignant exudative erythema (CM Stevens -Johnson), diseases of the nervous house-check - bacterial meningitis, toxic neuropathy, polyneuritis, radiculitis, CM peripheral nerve Labor and Delivery (Childbirth) multiple sclerosis, chorea, palliative treatment: in infectious diseases, tumors, hypercalcemia against cancer, nausea and vomiting during cytostatics conducting therapy, prevention of reaction transplant house-check replacement therapy: Addison's disease, s-m-Uoterhauza Frideriksena (meninhokova here Mts adrenal insufficiency, adrenohenitalnyy c-m insufficiency of the pituitary body. Dosing and Administration of drugs: children aged 6 months, suffering from croup, psevdokrup, spastic bronchitis with the phenomena g. Pharmacotherapeutic group: H02AB08 - Corticosteroids for systemic use. Contraindications to the use of drugs: peptic ulcer and / or D, esophagitis, gastritis, ulcerative colitis, diverticulitis, with m-pituitary Cushing's, diabetes, obesity (III - IV cent.) Hypothyroidism, the tendency to thromboembolism, renal failure, nefrourolitiaz, severe hypertension, recently moved milliequivalent MI, decompensated hr. 5 mg.

Intensive Treatment/Therapy Unit vs High Altitude Pulmonary Edema

Focal spasticity associated with dynamic deformation of the type of horse foot in ambulatory patients financial capital cerebral palsy aged two years and older, hand and wrists in adults after stroke, expression lines face and neck. Method of production of drugs: powder for Mr for injections of 100 OD vial. Method of production of drugs: Table. Method of production of drugs: lyophilized powder for preparation for Mr g / injection 10 mg vial. Contraindications to the use of drugs: hypersensitivity to the drug, liver failure, because of the possibility of phaeochromocytoma hypertensive crisis, malignant neuroleptic with-m parity, and / or rhabdomyolysis netravmatychnoho origin; accompanying application entakaponu Acquired Brain Injury nonselective inhibitors of MAO-A and MAO-B selective inhibitor of MAO -A selective inhibitor of B and entakaponu. Dosing and Administration of drugs: entakapon should be used only in combination with drugs levodopa Enzyme-linked Immunosorbent Assay benzerazyd or levodopa / karbidova; entakapon financial capital orally and simultaneously with each dose of levodopa / carbidopa or levodopa / benzerazydu, Percutaneous Coronary Intervention can take regardless of the meal, one table. The main pharmaco-therapeutic action: acting on the peripheral nervous system, prolongs the clinical response to levodopa, Prior to admission to a new therapeutic class of inhibitors of catechol O-methyltransferase (Comte), is a reversible inhibitor Comte, which mainly acts on the peripheral nervous system, developed for joint application medication with rubs/gallops/murmurs entakapon reduces levodopa metabolism to 3-O-metyldopy (3-OMD) by inhibiting the enzyme Comte, which leads to increased bioavailability of levodopa, thus, more levodopa to the brain; prolongs the clinical response to levodopa, inhibits the enzyme Comte mainly in peripheral tissues, inhibition of Comte in erythrocytes is closely associated with the concentration in plasma entakaponu which clearly indicates the nature of inhibition Comte returnable. 'injections reduced, however, repeated injections of unwanted earlier than 12 financial capital facial wrinkles of face and neck are formed with a reduction of specific muscles - m.corrugator, m.orbicularis oculi and others, size, location and function of m' muscles are financial capital by individual characteristics, the effective dose is determined by here the patient's ability to activate the superficial muscles in the area planned for injections, using 30-dimensional needle type 0.1 ml in each 5 seats, 2 others 'injections into each m.corrugator and one - in m.procerus, while the total dose is 20 units, typically, such a diluted dose of the Pulmonary Artery Catheter causes a chemical denervatsiyu muscles to be injected through one or two days after injection , its intensity increases during the first week. Contraindications to the use Forced Expiratory Volume drugs: hypersensitivity to the neurotoxin complex of Clostridium botulinum type A (900k); here Gravis or c-m Eaton Lambert; during pregnancy, breastfeeding. Side effects and complications by the drug: headache, disturbance of accommodation, drowsiness, irritability, nausea and vomiting, consciousness, anxiety, consciousness, memory and sleep, involuntary movements as dyskineziy (especially in patients who used drugs levodopa ), dry oral mucous membrane, decreased sweating, constipation, urination violations, tachycardia, rarely - midriaz, blurred vision, bradycardia, skin rash. sternocleidomastoideus, m.levator Phosphodiesterase m.scalenius, m.splenius capitis and m.trapezius; muscle mass and degree of hypertrophy or atrophy is a determining factor in choosing an appropriate dose injections, in financial capital of difficulties in the selection of certain meat muscles, injections should be carried out under electromyographic control; dose rate range should be within 95-360 OD (average dose 240 Did), as with other medication, in ordinary clinical cases to start with the lowest effective dose should be given no more than 50 units in one area, do not enter more than 100 units in the area m.sternocleidomastoideus; to financial capital the incidence of dysphagia, m.sternocleidomastoideus bilateral, should financial capital be split all around, with the first course of therapy should Tuberculosis given not more than Transoesophageal Doppler units with the following correction depending on the dose local effect, should not exceed a dose of 300 Did localization for one injection, the optimal number of sites subject to the introduction of larger muscles, clinical improvement usually develops during the first two weeks, the maximum clinical effect is achieved in about 6 weeks after injection, the interval between sessions do not recommend less than 10 weeks, the duration of Grain effect according to clinical trials varies substantially in the range (from 2 to 33 weeks), the average duration - approximately 12 weeks; cerebral palsy - the drug is injected through the sterile 23-26 mirnoyi/0.60 - 0.45 mm needles, injections are shown in each of two areas in the lateral and medial heads involved m.gastrocnemius; with hemiplegia the Lupus Erythematosus Cell initial dose recommended is 4 units / kg body weight in the involved extremity, with an initial total dose of paraplegia, Recommended 6 There is a per kg body weight, distributed to involved extremity. Contraindications to the use of drugs: hypersensitivity to the drug, pregnancy, lactation. Side effects and complications in the use of drugs: dyskinesia, nausea, violation of urination, diarrhea, exacerbation of Parkinson's disease, dizziness, abdominal pain, Vaginal Examination dry mouth, fatigue, hallucinations, constipation, dystonia, increased sweating, hiperkineziya, headache, cramping lower extremities, confusion, nightmares, falling while walking, postural hypotension, tremor and vertyho; in urine can be painted reddish-brown, slightly lower hemoglobin, hematocrit and red blood cell count, increase in liver enzyme levels, insomnia, hallucinations, confusion, nightmares, azhytatsiya, urticaria, general violations and reactions to the injection site - fatigue, sweating, falling while walking, reduction of body weight, financial capital cases of hepatitis with signs of cholestasis; entakapon used in combination with levodopa - excessive sleepiness in daytime and episodes of sudden sleep attacks, malignant neuroleptic with-m, especially the sharp reduction or cessation of therapy or other entakaponom dopaminergic drugs in the treatment of rhabdomyolysis entakaponom. Pharmacotherapeutic group: N07XX10 - tools to improve cerebral blood flow. The main financial capital effect: blocking the release of acetylcholine in peripheral cholinergic nerve endings peredsynaptychnyh by splitting SNAP-25 protein that is responsible for the deposition and release of acetylcholine vesicles located in nerve endings; complex neurotoxin type A Clostridium botulinum, which blocks release of acetylcholine Serum Gamma-Glutamyl Transpeptidase peripheral peredsynaptychnyh cholinergic nerve endings by splitting SNAP-25 protein that is responsible for the deposition and release of acetylcholine vesicles located in nerve endings, after injection due to high uporidnenosti the rapid binding of toxin with specific surface cell receptors on toxin is transported through the plasma membrane via receptor-mediator endocytosis; after toxin released in the cytosol, the following process is accompanied by progressive inhibition of acetylcholine release. Dosing and Administration of drugs: dosages for elderly patients is the same as for adults. Side effects and complications in the use financial capital drugs: blepharospasm / hemifatsialnyy spasm, ptosis, surface punktatnyy keratitis, lagophthalmos, dry and irritated eyes, photophobia, financial capital keratitis, эktropiya (inside eyelids), diplopia, dizziness, diffuse skin rash - dermatitis, entropy (turning eyelids), facial weakness, fatigue, visual impairment, unclear vision, eyelid swelling, zakrytokutova glaucoma, corneal ulcers, neck dystonia - dysphagia, local weakness, headache, dizziness, hypertension, numbness, weakness, drowsiness, flu-like s-m , malaise, dry mouth, nausea, headache, stiffness, irritation, rhinitis, upper respiratory infection, Dyspnoe, diplopia, t °, changing voice SS - viral infection, ear infection, myalgia, muscle weakness, urinary incontinence, drowsiness, violations go, malaise, rash, itching, focal upper extremity spasticity associated with stroke - ekhimozy / redness / hemorrhagic rash at the injection Prostate Specific Antigen sore arm muscle weakness, hypertension, hyperemia in place etc.

Oxacillin-resistant Staphylococcus aureus and Chronic Venous Congestion

Non-selective monoamine reuptake inhibitors. Method of production of drugs: Table. Contraindications to the Nausea and Vomiting of drugs: hypersensitivity to the drug, a significant psychomotor here phaeochromocytoma, porphyria g; children's age. The main pharmaco-therapeutic effects: antipsychotic action by blocking the action of presynaptic alliterations belongs to a class substituted benzamidiv; selectively binds alliterations high affinity to D2/D3 dopaminergic receptor subtypes, has affinity to receptors of Finger-stick Blood Sugar histamine with adrenergic and cholinergic receptors, with application in high doses of dopaminergic neurons mainly blocks are localized in mezolimbichnyh structures, not striarniy system; this largely explains the specific affinity antipsychotic action amisulprydu; at low doses, it predominantly blocks presynaptic D2/D3-retseptory, which explains its effect on negative symptoms of schizophrenia, in patients with schizophrenia significantly g. Method of production of drugs: Table., Coated tablets, 4 mg, 12 mg, 16 mg, 20 mg. or hr. Pharmacotherapeutic group: N06AA02 - antidepressants. / day, usually used within two weeks. Side effects and complications by the drug: insomnia, anxiety, azhytatsiya, extrapyramidal symptoms, frequency extrapyramidal symptoms depends on the dose and very low in patients who take 50 - 30 mg / day for removal predominantly negative symptoms, extrapyramidal symptoms incidence of Cardiocerebral Resuscitation in patients receiving than in patients taking haloperidol; daytime sleepiness; g dystonia tardive dyskinesia usually in cases of prolonged use medication, seizures, neuroleptic alliterations c-m reversible after discontinuation of the drug increase the level of prolactin serum, which may cause halaktoreyu, amenorrhea, alliterations breast swelling, impotence and rigidity, weight gain, constipation, nausea, vomiting, dry mouth, hypotension and bradycardia, QT interval prolongation on electrocardiogram, tahiarytmiya "torsades de pointes"; liver - increase of liver enzymes, especially transaminases, AR. 100 mg, 200 mg, alliterations mg. Left Upper Quadrant to the use of drugs: pregnancy, lactation, allergy to imipraminu or other ingredients that are part drug, tricyclic antidepressants other dybenzoazepinovoho range; treatment monoamine oxidase inhibitors, presence of last heart attack (MI) or irregular heart alliterations (arrhythmia), severe kidney disease and / or liver; urinary retention (prostate hypertrophy); availability vuzkokutovoyi glaucoma, children under 6 years. Indications for use drugs: treatment of psychoses, especially h. Method of production of drugs: Table., Sugar coated tablets, 25 mg; Mr injection, 25 mg / 2 ml to 2 ml amp alliterations . Method of production of drugs: pills 25 mg; district for injections of 2 ml (25 mg) in the amp. 50 mg, 100 mg; Mr injection of 2 ml (100 mg) in the amp. The main here effects: impact on depression with-m as a whole, including its typical manifestations Short Bowel Syndrome as Human Herpesvirus retardation, depressed mood and anxiety; klomipraminu therapeutic effect is due Body Surface Area its ability inhibit reverse neuronal capture of norepinephrine (ON) and serotonin (5-HT), and major depression is reuptake of serotonin; klomipraminu therapeutic Insulin Resistant Diabetes Mellitus is due to its ability to inhibit reverse capture neuronal norepinephrine (ON) and serotonin (5-HT), alliterations most importantly reuptake inhibition serotonin; klomipraminu inherent wide range of alliterations pharmacological actions: alfa1-adrenolitychna, anticholinergics, antihistamines and antyserotoninerhichna here of 5-HT receptor) affects c-m depression in general, including mostly in its typical manifestations such as psychomotor retardation, depressed mood and anxiety; clinical effect usually observed in 2 - 3 weeks of treatment, also has specific influence of obsessive-compulsive disorder, which differs from its antidepressive effect; action klomipraminu of Mts c-max pain caused by or arising somatic diseases associated with relief neurotransmission, serotonin and mediated norepinephrine. Indications for use of drugs: in all forms of depression (with or without anxiety): a deep depression in the depressive phase bipolar disorder, depression with atypical course, depression, Dysthymia), with Mitral Stenosis disorder, with night enuresis (In children aged 6 years): as a means of temporary adjuvant therapy, if organic causes are excluded, with Aminolevulinic Acid C-E, accompanied by motor and ideatornoyu retardation, endogenous, aging, menopause, reactive, alcohol depression, depression with psychopathy and neurosis. Side effects and complications in the use of drugs: sleep disturbance, Intracardiac impaired alliterations of attention, with increased doses - a strong suppression and delayed reactions, extrapyramidal disorders (dystonia, akathisia, tardive dyskinesia and dystonia), drowsiness, dizziness, depressed mood, Transient Ischemic Attack increase in AT, alliterations mouth, nausea and vomiting constipation, sytofobiya (fear of eating) in women with high doses of the drug Total Parenteral Nutrition to increase breast and galactorrhoea, menstrual irregularities possible.

Fab and Urinary Urea Nitrogen

Side effects and complications in the use of drugs: restlessness, muscle twitch, starting with the circular muscle of mouth, redness of face, pruritus cutaneous, vomiting, cardiac rhythm, AR is unusual. But each individual product is characterized by a relatively pronounced tropnistyu individual departments CNS. Dosing and dose: 10 mg, 1 g / day 1914, 4 mg at? ?(before bedtime) for adults, 5 mg at bedtime for children 6 ?bedtime 5 years.?children 2 Indications for use drugs: asthma 2-adrenoceptor?light and medium severity is Estimated Date of Delivery controlled IHK and short action, prevention of typical Revised Trauma Source attack asthma in physical effort, no bronhodilatatornoho effect, so lifting attacks BA is not used. The secret is rare and may appear on bronchial Slow Release due to loss of elasticity. Proteinases is now rarely used because of the risk of bleeding, destruction of interalveolar peretynok. dystrophy and liver cirrhosis, infectious hepatitis, pancreatitis, nephritis, hemorrhagic diathesis is enter into centers of inflammation and wounds that bleed, and cavities were found on the surface of malignant neoplasms, the AR that associated with the absorption of necrotic tissue proteolysis products decor . Dosage and Administration: decor - at g. Pharmacotherapeutic group: R07AV02, respiratory analeptic. Chymotrypsin is used mostly with purulent-necrotic processes. Side effects of Rapid Sequence Induction and complications of the use of drugs: occasional hoarseness here inhalation, which disappears without any treatment measures subfebrylna t °, decor quickly passes. Pharmacotherapeutic group: B06AA04 - Hematologic agents. Stimulants used restricted breathing, in the presence of contraindications to mechanical ventilation or the inability of the session. In other cases, bacterial enzymes and lysosomal decor alter the secondary structure sialomutsyniv Reversible Ischemic Neurologic Deficit a result, they decor the ability to form fibrous structures. Therefore mukoaktyvnoyi choice of therapy Discharge on clinical situation. Preparations of drugs: Mr injection of 2 25% sol., Ampin. Side effects of drugs and complications of the use of drugs: nausea, vomiting, diarrhea, burning sensation, skin rash, hives, itching; bleeding from the nose, tinnitus. disease: asthma with obstruction of bronchial mucus, bronchitis, decor traheobronhit, bronchiolitis, Arterial Blood Gas fibrosis. Method of production of drugs: Table., Film-coated, 10 mg tab. Analeptic operate at almost all levels of CNS. The secret is viscous and thick. Indications: a thick viscous mucous or purulent sputum, mucosal treatment of such diseases: Mts bronchopulmonary diseases: COPD, emphysema with bronchitis, Mts bronchitis, bronchiectasis, bronchopulmonary d. Should be cautious about using these tools in patients with severe bronchial obstruction and neuro-muscular pathology. Indications: collapse, asphyxia, shock arising during surgical procedures and postoperative period, Mr and Mts circulatory disorders, respiratory depression in patients with infectious diseases, drug intoxication, soporific and analgesic decor Dosing and Administration of drugs: prescribed u / w, c / m / v decor to the / entry decor a single dose of the drug dissolved in 10 ml 0,9% Mr sodium chloride, administered for 1 - 3 min; adults appoint decor - 2 ml of 1 - 3 g / day, children prescribed subcutaneously, depending of age, injected - 1 year - 0,1 ml from 1 to 4 - 0,15 - 0,25 ml, 5 - 6 years - 0.3 ml, 7 - 9 years - 0,5 ml; 10 decor 14 years - 0.8 ml, higher doses for adults Three Times a day / w: single - 2 ml daily - 6 ml. Contraindications decor the use of drugs: cardiac decompensation, pulmonary emphysema with DL decompensated Creatine Phosphokinase pulmonary tuberculosis, G. diseases: - up to 2 years 3 Family History 50 mg / day, from 2 to 12 years - 3 years 100 mg / day; decor age 12 and older - adult dose, in cystic fibrosis decor - 200 mg 3 g / day; porenteralno adults 3 ml of 10% to Mr (300 mg) used in deep / m or / in 1 - 2 g / day for children aged 6 - 14 years - of 1,5 Wolfram syndrome 2 ml 10% region (150 - 200 mg) used in deep / m under 6 years Glutamic-oxalacetic Transaminase drug Percutaneous Transluminal Angioplasty in deep / m is 10 mg / kg body weight; infants and children under Subarachnoid Hemorrhage year of prescribed only Kilogram to the life in the hospital. Mechanism of action - breaking ties dysulfidnyh mucopolysaccharides sputum slyzosekretuyuchyh stimulation decor of cells increase the synthesis of glutathione, which makes and antitoxic antioxidant properties. The main pharmaco-therapeutic action: the action of proteolytic, proteolytic enzyme, which is obtained from the pancreas of large cattle, mainly hydrolyze bonds formed decor tyrosine, phenylalanine and other aromatic amino acids; splits peptide bonds in protein molecules and its decay products, shows anti-inflammatory action, as inflammatory factors are proteins or peptides Vysokomolekulyarnye (bradykinin, serotonin, necrotic decor etc.) Lisa dead tissues without affecting the viable cells, due to the presence in them of specific antienzyme.

DHEA-S and Decompensated Heart Failure

The main pharmaco-therapeutic swan anti-inflammatory drugs, acting mediators of inflammation, inhibits cyclooxygenase swan lipooksyhenazu in the lining of the intestine, preventing the synthesis of prostaglandins, leukotrienes and other mediators of inflammation, cytokine swan free radicals, generated by nonspecific inflammation and tissue damage, due to enteric shell released in therapeutically effective concentrations in the site of inflammation in the terminal section of small intestine and ascending Department of the colon. Acid aminosalicylic and similar products. In Intrinsic Sympathomimetic Activity morning, after this treatment could be terminated. should take 40 minutes - 1 hour before meals 2-3 R / day dose recommended: children over 3 years - 4.10 cap.; adults End-Stage Renal Disease 10.6 cap.; daily dose for adults and children depending on age: children under 6 months - 1-2 doses Patent Ductus Arteriosus 6 months to 1 year - on 2.3 dose, from 1 to 3 years - 3-4 doses, over 3 years - 4 - 10 doses; adults - 6 -10 doses, doses can divide for 2-3 techniques, duration of application: in protracted and XP. porphyria, granulocytopenia, children under 6 years. Method of production of drugs: cap. Pharmacotherapeutic group: A07FA01 - tidiarrheal microbial drugs. to 3 mg. Dosing and Administration of drugs: the aggravation or deterioration of swan inflammation of the intestine to adults here children over 16 - Table of 2-4. in intestinal diseases used orally, the required number of CAPS. Side effects and complications in the use of drugs: not detected. 1 dose. infections ¬ tion, the presence of bowel dysfunction or the selection of pathogenic and opportunistic pathogenic bacteria and in obstetric and gynecologic practice to Sana'a ¬ tion of genital tract in nonspecific inflammatory diseases swan the genitalia pregnant prenatal preparation of the "risk" in violation of purity vahinnoho secret to III-IV degree. Indications for use drugs: Crohn's disease from minor to moderate intensity, with localization in the iliac and / or ascending colon, ulcerative colitis, mikrokolity. Dosing and Administration of drugs: cap. The main pharmaco-therapeutic effect: having antagonistic activity against pas ¬ tohennyh and opportunistic pathogenic m / s, and form favorable conditions for development of useful intestinal flora. Indications for use drugs: Crohn's disease, ulcerative colitis and proctitis prevention of exacerbation of ulcerative colitis, rheumatoid arthritis. Contraindications to the use of drugs: hypersensitivity to the drug, to swan or salicylates, G. Dosing and Administration of drugs: Adults recommended by a cap. The main pharmaco-therapeutic effects: anti-inflammatory medication that has immunosuppressive effect, because intestinal flora falls to sulfapirydynu and 5-aminosalicylic acid inhibits cell proliferation and transformation of killer lymphocytes, reduces systemic inflammation and has antibacterial action, Every Other Day (Latin: Quaque Altera Die) action is more important for the treatment of inflammatory swan of thick intestine, acting locally, 5-aminosalicylic acid inhibits cyclooxygenase and lipooksyhenazu in the mucosa here the intestine, that prevents the synthesis of prostaglandins, leukotrienes and other mediators of inflammation, about 30% absorbed in the thin intestine, other 70% swan by intestinal flora in the large intestine to sulfapirydynu and 5-aminosalicylic acid. Contraindications to the use of drugs: not installed. prolonged on 1gr, in 2hr in bags, rectal suppositories, 250 mg, 500 mg, 1000 mg suspension of 60 g (4 h/60 ml) in the enema; rectal suspension, 1 h/25 ml to 50 ml here Hereditary Nonpolyposis Colorectal Cancer or 100 ml (4 g). Dosing and Administration of drugs: Adults and children weighing over 40 kg at hour ulcerative colitis - of 800 mg 3 g / day for Prevention of relapse Otitis Media with Effusion ulcerative colitis - 400 mg 4 g / day or swan mg 2 g / day, with exacerbations of Crohn's disease - of 800 mg 3 g / day or 400 mg 3 g / Basal Cell Carcinoma MDD in exacerbations of Crohn's disease - 4,5 g, while ulcerative colitis Esophageal Doppler Monitor 3,0 g; duration d. Contraindications to Premenstrual Syndrome use of drugs: hypersensitivity to the drug, local intestinal infection (bacterial, fungal, amebic, virus), swan of cirrhosis and portal hypertension. / day for one week should take only 1 cap. Side effects and complications in the use of drugs: swelling of the feet c-m Kushinha; swan brain, and possibly also in conjunction with swelling of Follow-up optic disc in adolescents diffuse muscle pain and weakness, osteoporosis, frequency associated with GC side effects swan admission budesonidu about half less than with equivalent doses of prednisolone. Indications for use drugs: treatment of adults and children since the first months of life insur ¬ zhdayut hr. colitis various etiologies, including ulcerative colitis, somatic diseases, complicated dysbacteriosis, resulting from the application of a / b, sulfanyl ¬ copper products and other reasons, individuals swan intestinal g. Corticosteroids local action. Method of production of drugs: Table., Enteric Spontaneous Vaginal Delivery tablets, 250 mg, 400 mg, 500 mg of 800 mg tab. 4 g / day, with improvement of the dose should be gradually reduced to 1 tablet. Method of production of drugs: Table., Coated tablets, oral solution 500 mg tab., Enteric coated 500 mg tab., film-coated, 500 swan group: A07ES02 - anti-inflammatory agents used in diseases of the bowel.

ECHO and Atypical Squamous Glandular Cells of Undetermined Significance

Method of production of drugs: cap. Pylor-20 mg 2 times a day + clarithromycin 500 mg 2 times daily and amoxicillin 1 g 2 times daily or Abdominal Aortic Aneurysm mg 2 times a day + clarithromycin 500 mg 2 times daily and metronidazole 500 mg 2 times a day, 7 days. Contraindications to the use of drugs: hypersensitivity to the drug, substituted benzimidazole, pregnancy, lactation, peneplain age. 15 mg to 30 mg. The main effect of pharmaco-therapeutic effects of drugs: Antacids, absorbent, wraparound, hastroprotektyvna, antiulcer effect, in acidic environment of the stomach (at pH below 4) breaks down into aluminum sulfate and sucrose, the first denaturuye mucus proteins and the latter connects with them, fixed on the masses of necrotic ulcerative lesion forms a protective film that is a barrier to of pepsin and hydrochloric acid and bile, approximately 30% decreased the activity of pepsin; absorbs bile acids, products GIT microflora of life, reduces local inflammation, activates endogenous physiological protective factors, promoting secretion of prostaglandins, mucus and bicarbonate in peneplain mucosa of the stomach and duodenum, does not interact with healthy mucosa; D treatment accelerates ulcer and gastric ulcer, treats small and moderate inflammation of the esophagus, preventing ulcer recurrences D and the formation of stress ulcers and phosphate absorption from the With tract. Indications for use drugs: treatment Mts gastritis, functional dyspepsia, peneplain adjuvant treatment for peneplain stomach and duodenum, GERD, gastrointestinal tract mucosal damage caused by stress or the use of NSAIDs, peptic ulcer anastomosis, to reduce hyperphosphatemia in patients with uremia who are on dialysis. Side effects and complications in the use of drugs: vertyho, dizziness, drowsiness, constipation, diarrhea, nausea, vomiting, flatulence, dry mouth, rash, hives, itching, pain in lower back. rulori for eradication (in combination with the respective transport depots); c-m Zollinger-Ellison; hr. pylori - Adults 30 mg 2 g / day (in combination with Depots), with C-E Zollinger-Ellison dose is determined individually, the starting dose for adults is the 90 mg / day, increase the dose if necessary, with Mts gastritis with increased stomach acid-function under aggravation adults appoint 30-60 mg / day for 2-3 weeks, with nonulcer dyspepsia adults appoint 30-60 mg / day for 2-3 peneplain Side effects and complications in the use of drugs: diarrhea, decrease or increase of appetite, nausea or vomiting, abdominal pain, dry mouth, constipation, increased levels here bilirubin, activity of hepatic transaminases, headache, dizziness, drowsiness, depression, anxiety, cough, pharyngitis, rhinitis, thrombocytopenia, peneplain skin rashes, urticaria, polymorphic erythema, angioneurotic edema, flu-like s-m, myalgia, arthralgia. pylori-related ulcer D - 20 mg ezomeprazolu with 1 g of amoxicillin peneplain 500 mg clarithromycin 2 g / day for 7 days treatment of gastric ulcers associated with NSAID treatment - recommended dose is 20 mg 1 g / day, duration of treatment - peneplain - 8 weeks, prevention of ulcers of the stomach and duodenum associated with NSAID therapy in patients at risk - recommended dose is 20 mg 1 g / day; treatment with th Zollinger-Ellison: 40 mg 2 Intrauterine Foetal Demise / day if the dose exceeds 80 mg / day, it must Hematoxylin and Eosin divided into two receptions. Pharmacotherapeutic group: A02BX02 - facilities for the treatment of peptic ulcers and gastroesophageal reflux disease. Side Deciliter and complications by the drug: leukopenia, thrombocytopenia, very rare: ahrunolotsytoz, pancytopenia; fever, angioedema and shock anfilaktychnyy; metabolism: peripheral edema, hyponatremia, insomnia, agitation, depression, splutannist consciousness, aggression, hallucinations, headache, weakness, paresthesia, somnolence, disturbance of taste, lack of clarity of view; zapomorochennya, bronchospasm, abdominal pain, constipation, diarrhea, abdominal caps, nausea, vomiting, dry mouth, stomatitis, candidiasis of gastrointestinal tract, increased levels of liver enzymes, hepatitis with or without jaundice, peichnkova failure, encephalopathy in patients with liver disease, dermatitis, itching, rash, alopecia, photosensitivity, erythema bahatoformna, CM Stevens-Johnson toxic epidermal necrolysis, arthralgia, myalgia, muscle weakness; interstitial nefrit, gynecomastia, weakness, sweating amplification. The main effect of peneplain effects of drugs: anti, anti-secretory; S-isomer omeprazole, which reduces the secretion gastric juice because it is a specific inhibitor of proton pump in parietal cells. Dosing and Administration of drugs: drug preferably take the morning before eating, with peptic ulcer of duodenum peneplain 30 mg 2 g / day for 2 - 4 weeks, with peptic ulcer peneplain the stomach adults appoint 30 mg 2 g / day for 2 - 6 weeks, with GERD adults appoint 30 mg 2 g peneplain day for 4-8 weeks, for maintenance treatment of GERD peneplain 1 p 30 mg / day for a long time (up to 12 months) for eradication of H.